Obesity

Circulating lipid subfractions and the risk of longitudinal adiposity progression: findings from the China Kadoorie Biobank

Int J Obes (Lond)Published Prospective cohort study

Authors' conclusion

Cholesterol-enriched lipoproteins, particularly in medium-to-small subclasses, may contribute to long-term obesity progression risk, while elevated TG subfractions primarily reflect current obesity status.

Study context

Population
China Kadoorie Biobank participants with baseline NMR data and anthropometric measurements at baseline and second resurvey
Participants
1,502 participants
Exposure
Per SD higher circulating lipid subfraction trait
Outcome
Excessive adiposity increase: BMI increase of ≥5% from baseline
Follow-up
Median 8 years
Methodological detailsChina Kadoorie Biobank, modified Poisson regression
  • China Kadoorie Biobank
  • Modified Poisson regression

Main finding

As reported in the abstract

Excessive adiposity increase (≥5% BMI increase)

Participants with ≥5% increase in body mass index (BMI)

33.3%

High baseline cholesterol percentages in most LDL and high-density lipoprotein (HDL) subclasses: elevated risk of excess adiposity increase (RRs per SD)

1.09-1.18

Triglyceride (TG) enrichment in most lipoprotein particles, except larger VLDL particles: inverse association with adiposity progression (RRs per SD)

0.90-0.80

Observational data: associations, not effects.

Further findings

Most TG-enriched subfractions were associated with baseline obesity status but inversely with longitudinal adiposity progression
Cholesterol enrichment in HDL and LDL subclasses was associated with long-term adiposity increases, yet inversely with baseline adiposity

Original publication

Circulating lipid subfractions and the risk of longitudinal adiposity progression: findings from the China Kadoorie Biobank. Int J Obes (Lond). Published 21 April 2026. doi:10.1038/s41366-026-02089-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.